CGT · 혈액암 (AML/ALL)

405개 · ADC 890 · Antibody 4097 · CGT 2985 · 다음 갱신 D-5 · 마지막 9월 2일

PopularRecently updatedCuratedMost trialsNeeds refreshORRLatestPhase 3FDA approved405 programs
CGTCurated CoreFDANovartisApproved

tisagenlecleucel (Kymriah, tisa-cel)

ALL, DLBCL, FL · CD19

#CD19#CGT#Approved#FDA-approved#BioJungboMoa-pick+5
Trials 48Status Approved
CGTAAVCurated CoreFDASpark TherapeuticsApproved

voretigene neparvovec (Luxturna, AAV2-hRPE65v2, voretigene neparvovec-rzyl)

Inherited retinal dystrophy due to confirmed biallelic RPE65 mutations · RPE65 (AAV2)

#RPE65AAV2#CGT#Approved#FDA-approved#BioJungboMoa-pick+5
Trials 7Status Approved
CGTStandard DatabasestaleAstraZenecaPhase 2

autologous CD19-directed chimeric antigen receptor (CAR, autologous CD19-directed chimeric antigen receptor, autologous CD19-directed chimeric antigen receptor (CAR) T-cells)

Relapsed Non Hodgkin Lymphoma; Relapsed Adult ALL · CD19

#CD19#CGT#Phase2#Popular#cell-gene-therapy+5
Trials 154Status Recruiting
CGTStandard DatabasestaleAmgenPhase 3

Asparaginase Erwinia chrysanthemi (Asparaginase Erwinia chrysanthemi, Asparaginase Erwinia chrysanthemi (recombinant)-rywn, recombinant)

Acute Lymphoblastic Leukemia; Acute Lymphoblastic Lymphoma · Acute Lymphoblastic Leukemia

#AcuteLymphoblasticLeukemia#CGT#Phase3#Popular#cell-gene-therapy+5
Trials 134Status Recruiting
CGTLimited DatastaleFundamenta Therapeutics, Ltd.Phase 1

Chimeric Antigen Receptor T-cells (Chimeric Antigen Receptor T-cells)

Leukemia, Acute Lymphocytic (ALL); Leukemia, Acute Myelogenous (AML) · Platinum-Resistant Ovarian Carcinoma

#Platinum-ResistantOvarianCarcino#CGT#Phase1#Popular#cell-gene-therapy+5
Trials 93Status Active
CGTLimited DatastaleNeotropixPhase 1

biological agent (Seneca Valley Virus, Seneca Valley Virus (biological agent))

Carcinoid; Neuroendocrine · Carcinoid

#Carcinoid#CGT#Phase1#Popular#cell-gene-therapy+5
Trials 93Status Active
CGTLimited DatastalePorteus, Matthew, MDPreclinical

Allogeneic Stem Cell Transplant (Allogeneic Stem Cell Transplant)

Hematologic Diseases · Hematologic Diseases

#HematologicDiseases#CGT#Preclinical#Popular#cell-gene-therapy+4
Trials 91Status Recruiting
CGTStandard DatabasestaleHoffmann-La RochePhase 2

Interferon-Alfa-2b (Interferon-Alfa-2b)

Malignant Neoplasm of Pancreas Metastatic to Peritoneal Surface; Malignant Peritoneal Mesothelioma · Adult T-cell Leukemia-Lymphoma

#AdultT-cellLeukemia-Lymphoma#CGT#Phase2#Popular#cell-gene-therapy+5
Trials 88Status Active
CGTLimited DatastaleMerck Sharp & Dohme LLCPhase 1

Stem cell infusion (Stem cell infusion)

Leukemia; Lymphoma · Leukemia

#Leukemia#CGT#Phase1#Popular#cell-gene-therapy+5
Trials 62Status Active
CGTLimited DatastaleYake Biotechnology Ltd.Phase 1

chimeric antigen receptor T cell treatment (chimeric antigen receptor T cell treatment)

T Cell Lymphoma; T-cell Leukemia · FRα

#FR#CGT#Phase1#Popular#cell-gene-therapy+5
Trials 62Status Active
CGTStandard DatabasestaleGenzyme, a Sanofi CompanyPhase 2

stem cells (stem cells)

Acute Lymphoblastic Leukemia; Acute Myelocytic Leukemia · Acute Lymphoblastic Leukemia

#AcuteLymphoblasticLeukemia#CGT#Phase2#Popular#cell-gene-therapy+5
Trials 62Status Discontinued
CGTStandard DatabasestaleAlliance for Clinical Trials in…Phase 3

Allopurinol (Allopurinol)

B Acute Lymphoblastic Leukemia · Fallopian Tube Cancer

#FallopianTubeCancer#CGT#Phase3#Popular#cell-gene-therapy+5
Trials 61Status Discontinued
CGTLimited DatastaleHebei Senlang Biotechnology Inc…Phase 2

Autologous CAR-T cells (Autologous CAR-T cells)

Leukemia; Lymphoma · FRα

#FR#CGT#Phase2#Popular#cell-gene-therapy+5
Trials 61Status Active
CGTStandard DatabasestaleGlaxoSmithKlinePhase 2

topotecan hydrochloride (topotecan hydrochloride)

Fallopian Tube Carcinosarcoma; Fallopian Tube Clear Cell Adenocarcinoma · Fallopian Tube Cancer

#FallopianTubeCancer#CGT#Phase2#Popular#cell-gene-therapy+5
Trials 61Status Discontinued
CGTStandard DatabasestaleAbbottPhase 2

Pegylated asparaginase (Pegylated asparaginase)

B Lymphoblastic Leukemia · B Lymphoblastic Leukemia

#BLymphoblasticLeukemia#CGT#Phase2#Popular#cell-gene-therapy+4
Trials 60Status Recruiting
CGTStandard DatabasestaleAbbottPhase 2

Zidovudine (Zidovudine)

Lymphoproliferative Disorder; HHV-8 · Adult T-cell Leukemia-Lymphoma

#AdultT-cellLeukemia-Lymphoma#CGT#Phase2#Popular#cell-gene-therapy+5
Trials 60Status Recruiting
CGTStandard DatabasestaleSMT bio Co., Ltd.Phase 2

allogeneic Natural Killer cell ('SMT-NK' Inj, 'SMT-NK' Inj (allogeneic Natural Killer cell))

Biliary Tract Cancer · Biliary Tract Cancer

#BiliaryTractCancer#CGT#Phase2#Popular#cell-gene-therapy+4
Trials 58Status Active
CGTStandard DatabasestaleArtiva Biotherapeutics, Inc.Phase 2

Allogeneic NK cells (Allogeneic NK cells)

Refractory Rheumatoid Arthritis (RA); Idiopathic Inflammatory Myopathies (IIMs) · Non Hodgkin Lymphoma

#NonHodgkinLymphoma#CGT#Phase2#Popular#cell-gene-therapy+5
Trials 58Status Recruiting
CGTLimited DatastaleCoronado Biosciences, Inc.Phase 2

Allogeneic natural killer cells (Allogeneic natural killer cells)

Leukemia; Lymphoma · Fallopian Tube Cancer

#FallopianTubeCancer#CGT#Phase2#Popular#cell-gene-therapy+5
Trials 58Status Discontinued
CGTStandard DatabasestaleGenentech, Inc.Phase 2

L-Asparaginase (L-Asparaginase)

B Lymphoblastic Leukemia · B Lymphoblastic Leukemia

#BLymphoblasticLeukemia#CGT#Phase2#Popular#cell-gene-therapy+4
Trials 58Status Recruiting

1 / 21 pages

← PreviousNext →